LBTD (Lotus Bio-Technology Development) Liabilities-to-Assets : 2.13 (As of Dec. 2017)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Lotus Bio-Technology Development Liabilities-to-Assets?

Lotus Bio-Technology Development LBTD -99.99% Liabilities-to-Assets is 2.13 as of Dec. 2017.

Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities, calculated as total liabilities divided by total asset. Lotus Bio-Technology Development's Total Liabilities for the quarter that ended in Dec. 2017 was $0.12 Mil. Lotus Bio-Technology Development's Total Assets for the quarter that ended in Dec. 2017 was $0.06 Mil. Therefore, Lotus Bio-Technology Development's Liabilities-to-Assets Ratio for the quarter that ended in Dec. 2017 was 2.13.

Lotus Bio-Technology Development  (OTCPK:LBTD) Liabilities-to-Assets Explanation

Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities. It can vary greatly across different industries, as they have different capital structure. A high Liabilities-to-Assets ratio (more leveraged) suggests that the company might have potential solvency problems, or even a signal of financial distress. Conversely, a low Liabilities-to-Assets ratio usually indicates a healthy financial situation. However, it may also suggest that the company is not expanding or not making good use of debt.

Lotus Bio-Technology Development Liabilities-to-Assets Related Terms

Lotus Bio-Technology Development Liabilities-to-Assets Historical Data

* Premium members only.

The historical data trend for Lotus Bio-Technology Development's Liabilities-to-Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lotus Bio-Technology Development Liabilities-to-Assets Chart

Lotus Bio-Technology Development Annual Data
Trend Mar11 Mar12 Mar13 Mar14 Mar15 Mar16 Mar17
Liabilities-to-Assets
Get a 7-Day Free Trial 3.25 0.00 23.50 13.40 0.00

Lotus Bio-Technology Development Quarterly Data
Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17
Liabilities-to-Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 22.00 0.00 0.00 0.00 2.13

LBTD vs SNES, CVAT: Liabilities-to-Assets Comparison

For the Agricultural Inputs subindustry, Lotus Bio-Technology Development's Liabilities-to-Assets, along with its competitors' market caps and Liabilities-to-Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lotus Bio-Technology Development Liabilities-to-Assets vs Agriculture Industry

For the Agriculture industry and Basic Materials sector, Lotus Bio-Technology Development's Liabilities-to-Assets distribution charts can be found below:

* The bar in red indicates where Lotus Bio-Technology Development's Liabilities-to-Assets falls into.


Lotus Bio-Technology Development Liabilities-to-Assets Calculation

Liabilities-to-Assets ratio measures the portion of the total liabilities to the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Liabilities-to-Assets ratio is calculated by dividing total liabilities by total asset.

Lotus Bio-Technology Development's Liabilities-to-Assets Ratio for the fiscal year that ended in Mar. 2017 is calculated as:

Liabilities-to-Assets (A: Mar. 2017 )=Total Liabilities/Total Assets
=0.081/0
=N/A

Lotus Bio-Technology Development's Liabilities-to-Assets Ratio for the quarter that ended in Dec. 2017 is calculated as

Liabilities-to-Assets (Q: Dec. 2017 )=Total Liabilities/Total Assets
=0.117/0.055
=2.13

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Liabilities-to-Assets →
What does a Liabilities-to-Assets of 2.13 mean?
Lotus Bio-Technology Development (LBTD) has a Liabilities-to-Assets of 2.13 as of Dec. 2017. Liabilities-to-Assets equals total liabilities divided by total assets. It measures financial leverage. View historical data on Lotus Bio-Technology Development and its competitors.
Is Lotus Bio-Technology Development's Liabilities-to-Assets too high?
Lotus Bio-Technology Development's current Liabilities-to-Assets is 2.13.
How does Lotus Bio-Technology Development's Liabilities-to-Assets compare to SNES and CVAT?
Lotus Bio-Technology Development's Liabilities-to-Assets of 2.13 can be compared against companies in the Agriculture industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Liabilities-to-Assets for an Agriculture company?
A good Liabilities-to-Assets depends on the Agriculture industry context. However, Liabilities-to-Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Liabilities-to-Assets mean?
A high Liabilities-to-Assets can signal that a stock is expensive relative to its fundamentals. Liabilities-to-Assets equals total liabilities divided by total assets. It measures financial leverage. View historical data on Lotus Bio-Technology Development and its competitors. Lotus Bio-Technology Development's current Liabilities-to-Assets is 2.13. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lotus Bio-Technology Development stock overvalued right now?
Lotus Bio-Technology Development (LBTD) has a current Liabilities-to-Assets of 2.13. The current Liabilities-to-Assets is 2.13. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Liabilities-to-Assets calculated?
Liabilities-to-Assets is calculated from a company's financial statements. For Lotus Bio-Technology Development (LBTD), the current Liabilities-to-Assets is 2.13 as of Dec. 2017. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Lotus Bio-Technology Development Business Description

Address 108 2559 Parkview Lane, Port Coquitlam, BC, CAN, V3C6M1
Lotus Bio-Technology Development Corp is actively seeking out new opportunities in the Organic and Bio-technology space.